Niceritrol

This classification denotes an anti-lipidemic agent with the molecular formula C29H24N4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F54EHJ34MV, chemically known as 3-pyridinecarboxylic acid, 2,2-bis(((3-pyridinylcarbonyl)oxy)methyl)-1,3-propanediyl ester but generally known as niceritrol, which bears US NIH Compound Identifier 4476. European Medicines Agency schedules Niceritrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09227MIG. The term NICERITROL is an International Non-Proprietary Name. World Health Organization schedules niceritrol in its Anatomical Therapeutic Chemical (ATC) Classification. NICERITROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule niceritrol under HS 29333999 and SITC 51574. As of Q4 2014, NICERITROL remains the US FDA Preferred Term for this commodity. Niceritrol bears US NLM identifiers UMLS ID C0028009 and NCI Concept Code C75257. SMILES: O(CC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)C(=O)c1cccnc1.